HomeMOB • STO
add
Moberg Pharma AB (publ)
Previous close
kr 37.42
Day range
kr 36.52 - kr 38.88
Year range
kr 6.15 - kr 40.90
Market cap
1.80B SEK
Avg Volume
574.75K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 820.00K | — |
Operating expense | 8.39M | 25.70% |
Net income | -6.50M | -29.17% |
Net profit margin | -792.32 | — |
Earnings per share | — | — |
EBITDA | -7.76M | -23.51% |
Effective tax rate | 13.52% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 38.63M | -54.30% |
Total assets | 632.03M | 14.64% |
Total liabilities | 27.18M | 22.34% |
Total equity | 604.85M | — |
Shares outstanding | 27.96M | — |
Price to book | 1.73 | — |
Return on assets | -3.12% | — |
Return on capital | -3.22% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -6.50M | -29.17% |
Cash from operations | -3.79M | 32.42% |
Cash from investing | -17.82M | 48.34% |
Cash from financing | -312.00K | 65.49% |
Net change in cash | -21.92M | 46.54% |
Free cash flow | -19.07M | 58.03% |
About
Founded
2006
Website
Employees
9